AnaptysBio
ANAB
AnaptysBio (ANAB) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $70.00 from $75.00 | Aug 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $95.00 | Aug 24, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $95.00 | Jun 10, 2026 |
| Barclays | Maintained | Overweight | $75.00 from $63.00 | May 13, 2026 |
| UBS | Maintained | Buy | $76.00 from $60.00 | May 13, 2026 |
| Piper Sandler | Maintained | Overweight | $93.00 from $95.00 | May 4, 2026 |
| Leerink Partners | Maintained | Outperform | $85.00 from $66.00 | Apr 28, 2026 |
| Barclays | Maintained | Overweight | $63.00 from $79.00 | Apr 22, 2026 |
| UBS | Maintained | Buy | $60.00 from $90.00 | Apr 21, 2026 |
| Piper Sandler | Maintained | Overweight | $95.00 from $67.00 | Mar 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $66.00 | Mar 30, 2026 |
| UBS | Maintained | Buy | $90.00 from $70.00 | Mar 17, 2026 |
| Wedbush | Maintained | Outperform | $75.00 from $60.00 | Mar 12, 2026 |
| Truist Securities | Maintained | Hold | $50.00 from $36.00 | Mar 9, 2026 |
| Stifel | Maintained | Buy | $85.00 from $56.00 | Mar 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $66.00 from $51.00 | Mar 4, 2026 |
| Barclays | Maintained | Overweight | $79.00 from $78.00 | Mar 4, 2026 |
| Barclays | Maintained | Overweight | $78.00 from $55.00 | Jan 20, 2026 |
| UBS | Initiated Coverage | Neutral → Buy | $70.00 from $20.00 | Jan 7, 2026 |
| Barclays | Maintained | Overweight | $55.00 from $70.00 | Dec 17, 2025 |
Frequently asked questions
What is the latest analyst rating on ANAB?
On Aug 25, 2026, TD Cowen maintained AnaptysBio at Buy with a price target of $70.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.